Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse Transcriptase

Autor: Jennifer Fretland, Jeffrey Wu, Nidhi Arora, Fang‐Jie Zhang, Julie Q. Hang, Judy M. Suh, Stan Tsing, Seth F. Harris, Joshua Kennedy-Smith, Amber Paul, James Edward Paul Davidson, Sarah Sperry, J. Roland Billedeau, Mark D. Smith, Gabrielle Heilek, Klaus Klumpp, Guoping Su, Zachary Kevin Sweeney, Hassan Javanbakht, Amy S. Zhou, Taraneh Mirzadegan, Shelley K. Gleason, Yu Li, Ralf Roetz, Jesper A. Jernelius, Donald Roy Hirschfeld, Armando G. Villaseñor
Rok vydání: 2008
Předmět:
Zdroj: Journal of Medicinal Chemistry. 51:7449-7458
ISSN: 1520-4804
0022-2623
DOI: 10.1021/jm800527x
Popis: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are recommended components of preferred combination antiretroviral therapies used for the treatment of HIV. These regimens are extremely effective in suppressing virus replication. Structure-based optimization of diaryl ether inhibitors led to the discovery of a new series of pyrazolo[3,4-c]pyridazine NNRTIs that bind the reverse transcriptase enzyme of human immunodeficiency virus-1 (HIV-RT) in an expanded volume relative to most other inhibitors in this class.The binding mode maintains the beta13 and beta14 strands bearing Pro236 in a position similar to that in the unliganded reverse transcriptase structure, and the distribution of interactions creates the opportunity for substantial resilience to single point mutations. Several pyrazolopyridazine NNRTIs were found to be highly effective against wild-type and NNRTI-resistant viral strains in cell culture.
Databáze: OpenAIRE